golimumab
US/ɡoʊˈlɪm.jəˌmæb/
golimumab noun: a genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Noun
golimumab (uncountable)
- A genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Origin of golimumab
From [Term?] + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
Questions about golimumab
- What does golimumab mean?
- Golimumab means a genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
- What part of speech is golimumab?
- Golimumab is a noun.
- How do you pronounce golimumab?
- Golimumab is pronounced /ɡoʊˈlɪm.jəˌmæb/ (US).
Words near golimumab in the dictionary
Source and license
Adapted from Wiktionary: golimumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “golimumab.” Word.ws, https://word.ws/golimumab. Based on Wiktionary, CC BY-SA 4.0.
